1 month Gilead, MRK Report Data From Investigational Combination Study for HIVZacks

GILD and partner MRK advance novel investigational combination regimen, a weekly oral HIV treatment, to phase III.

Gilead (GILD) · Merck&Co (MRK)

20 hours Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X

2 days Market Digest: ADTN, EQR, GILD, NFG, PRU, MSCIYahoo Finance X

3 days Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’Insider Monkey X

3 days Merck Gets Positive CHMP Opinion for Keytruda in MesotheliomaZacks X

6 days Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer TherapyZacks X

7 days Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a BetZacks X

1 week Merck & Co., Inc. (MRK) UBS Global Healthcare Conference (Transcript)Seeking Alpha X

1 week GILD or VRTX: Which Is the Better Value Stock Right Now?Zacks X

2 weeks Merck & Co., Inc. (MRK): Among the Best Low Volatility Stocks to Invest In NowInsider Monkey X

2 weeks Gilead increases 2024 outlook, expects new drug filing by end of yearYahoo Finance X

2 weeks Gilead Beats on Q3 Earnings and Sales, Raises Annual OutlookZacks X

2 weeks Merck & Co., Inc. (MRK) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates EraInsider Monkey X

2 weeks Why Gilead’s Solid Q3 Earnings Could Point To A Dividend Surprise Next YearSeeking Alpha X

2 weeks Gilead Sciences (GILD) Q3 2024 Earnings Call TranscriptThe Motley Fool X

2 weeks Gilead Sprints To A Profit-Taking Zone After Riding Covid Drug To Beat And RaiseInvestor's Business Daily X

2 weeks Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidanceMarketWatch X

2 weeks Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy Right Now?Insider Monkey X

2 weeks Gilead Science to Report Q3 Earnings: What’s in the Cards?Zacks X

3 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X

3 weeks Gilead Sciences (GILD) Gains As Market Dips: What You Should KnowZacks X

3 weeks Merck & Co., Inc. (NYSE:MRK) Trading Down 2.9% – Here’s WhyMarketBeat X

3 weeks Merck (MRK) Q3 2024 Earnings Call TranscriptThe Motley Fool X

3 weeks Merck Q3 Earnings & Sales Top, Stock Down on Lowered ’24 ViewZacks X

3 weeks Merck (MRK) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks X

3 weeks Merck & Co., Inc. (NYSE:MRK) Trading Down 0.1% – Should You Sell?MarketBeat X

3 weeks Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by New York State Teachers Retirement SystemMarketBeat X

3 weeks Earnings Preview: Gilead Sciences (GILD) Q3 Earnings Expected to DeclineZacks X

3 weeks Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is ‘Too Low’Insider Monkey X

3 weeks Gilead Sciences (GILD) Stock Sinks As Market Gains: Here’s WhyZacks X

3 weeks Gilead Sciences (NASDAQ:GILD) Given Sector Perform Rating at Royal Bank of CanadaMarketBeat X

3 weeks Merck & Co., Inc. (NYSE:MRK) Trading Up 0.2% – What’s Next?MarketBeat X

4 weeks Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to AnalystsInsider Monkey X

4 weeks Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024Insider Monkey X

4 weeks Dumont & Blake Investment Advisors LLC Sells 5,026 Shares of Merck & Co., Inc. (NYSE:MRK)MarketBeat X

4 weeks Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of “Moderate Buy” by BrokeragesMarketBeat X

4 weeks Where Will Merck Be in 5 Years?The Motley Fool X

4 weeks Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock?Zacks X

4 weeks Merck & Co., Inc. (NYSE:MRK) Trading Down 0.2% – Time to Sell?MarketBeat X

4 weeks Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should KnowZacks X

4 weeks Why Gilead Sciences (GILD) Dipped More Than Broader Market TodayZacks X

4 weeks Marks Electrical Group (LON:MRK) Reaches New 1-Year Low – Should You Sell?MarketBeat X

4 weeks Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High – Still a Buy?MarketBeat X

4 weeks Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts?Insider Monkey X

4 weeks Narwhal Capital Management Buys 15,510 Shares of Merck & Co., Inc. (NYSE:MRK)MarketBeat X

4 weeks Merck (MRK) Advances While Market Declines: Some Information for InvestorsZacks X

1 month Zacks Research Predicts Lower Earnings for Merck & Co., Inc.MarketBeat X

1 month Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by Leerink PartnrsMarketBeat X

1 month Merck & Co., Inc. (NYSE:MRK) Shares Bought by Vest Financial LLCMarketBeat X

1 month Top Research Reports for Visa, Netflix & MerckZacks X

1 month Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?Zacks X